Christopher Murphy
Director Financiero/CFO en THIRD HARMONIC BIO, INC. .
Cargos activos de Christopher Murphy
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| THIRD HARMONIC BIO, INC. | Director Financiero/CFO | 04/01/2024 | - |
Historial de carrera de Christopher Murphy
Antiguos cargos conocidos de Christopher Murphy.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
Formación de Christopher Murphy.
| University of Notre Dame | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Irlanda | 2 |
Operativa
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| THIRD HARMONIC BIO, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Murphy
- Experiencia
